医学
埃利斯波特
佐剂
肝细胞癌
不利影响
免疫疗法
接种疫苗
内科学
危险系数
免疫系统
抗原
肿瘤科
免疫学
胃肠病学
T细胞
置信区间
作者
Jeong‐Hoon Lee,Yoon Lee,Minjong Lee,Min Kyu Heo,Jae–Sung Song,Kihwan Kim,Hyunah Lee,Nam‐Joon Yi,Kwang‐Woong Lee,Kyung‐Suk Suh,Yong‐Soo Bae,Yoon Jun Kim
摘要
Adjuvant DC vaccine for HCC was safe and well tolerated in phase I/IIa study, and preliminary efficacy data are encouraging to warrant further clinical study in patients with HCC after primary treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI